President
- Shinichi Noto, MS, PhD
Niigata University of Health and Welfare
Faculty of Rehabilitation
Center for Health Economics & QOL Research
Niigata, Japan
President-elect
- Makoto Kobayashi, MEng, PhD
COO
CRECON MEDICAL ASSESSMENT INC.
Tokyo, Japan
Past President
- Manabu Akazawa, PhD, MPH
Professor
Meiji Pharmaceutical University
Tokyo, Japan
Executive Committee Members
- Mie Azuma(nee, Kasai) PhD (HEcon), RPharm
Associate director
Eisai Co., Ltd.
Tokyo, Japan - Ataru Igarashi, PhD
Associate Professor
Dept. of Public Health, Yokohama City University School of Medicine.
Visiting Associate Professor
Dept. of Health Economics and Outcomes Research,
Graduate School of Pharmaceutical Sciences,
The University of Tokyo.
Tokyo, Japan - Shunya Ikeda, MD, PhD
Professor of Public Health
School of Medicine
International University of Health and Welfare
Narita, Japan - Makoto Kobayashi, MEng, PhD
COO
CRECON MEDICAL ASSESSMENT INC.
Tokyo, Japan - Shinya Saito, MD, PhD
Professor
Okayama University
Okayama, Japan - Kojiro Shimozuma, MD, PhD
Professor
Division of Health Services Research, Department of Biomedical Sciences,
College of Life Sciences,Ritsumeikan University
CHEERS: Comprehensive Unit for Health Economic Evidence Review and Decision Support,
Ritsumeikan University
Kusatsu, Japan - Takeru Shiroiwa, MPH, PhD
Chief Senior Researcher
Center for Outcomes Research and Economic Evaluation for Health (C2H),
National Institute of Public Health
Saitama, Japan - Chisato Hamashima, MD, DrMedSc
Professor
Department of Nursing, Faculty of Medical Technology,
Teikyo University
Tokyo, Japan - Takashi Fukuda, PhD
Director
Center for Outcomes Research and Economic Evaluation for Health (CORE2-Health),
National Institute of Public Health
Saitama, Japan - Kensuke Moriwakii, MSc, PhD
Associate Professor
Health Policy and Management Lab, Dpt. of Biomedical Sciences, College of Life, Ritsumeikan University
CHEERS: Comprehensive Unit for Health Economic Evidence Review and Decision Support,
Ritsumeikan University
Shiga, Japan
Councilors
- Tomohide Akase, PhD, MBA
Professor
Japan University of Economics, Graduate School of Business
Tokyo, Japan - Toshihiko Aranishi, Ph.D
Price, Reimbursement and Access
HTA Associate Director
Eli Lilly Japan K.K.
Kobe, Japan - Haku Ishida, MD, PhD
Haku Ishida, MD, PhD
Professor
Department of Medical Informatics and Decision Sciences
Yamaguchi University
Yamaguchi, Japan - Ataru Inagaki, MD, PhD
Professor
Aoyama Gakuin University
Tokyo, Japan - Ryo Iwata, BA, MSc Public Health
Regulatory Affairs
Director
Aerie Pharmaceuticals
Tokyo, Japan - Miyuki Ezura, MS
Advisor
Pharmacoeconomics, Corporate Planning Dept.
Otsuka Holdings Co., Ltd.
Tokyo, Japan - Shinya Ohno, Ph.D, MPH
Director
Medical PHC Initiative Dept.
Chugai Pharmaceutical Co., Ltd.
Tokyo, Japan - Koji Kawakami, MD, PhD
Professor and Chair
Kyoto University
Kyoto, Japan - Rei Goto, MD, PhD
Professor
Keio University
Yokohama, Japan - Mitsuhiro Sado, M.D., M.Sc., Ph.D.
Professor
Health Center
Keio University
Tokyo, Japan - Yurie Taguchi, PhD, MBA, MA
Abbott Japan LLC
Tokyo, Japan - Tomoyuki Takura,PhD
Project Professor
Department of Healthcare economics and Health Policy,
Tokyo University, Graduate school of Medicine/Faculty of Medicine
Tokyo, Japan - Makoto Tamura, Ph.D.
CEO / Founder
Healthcare System Planning Institute
Tokyo, Japan - Naohiro Nakahara, PhD
Zimmer Biomet G.K.
Tokyo, Japan - Shinichiro Yanagisawa, PhD
President
Himeji Dokkyo University
Himeji, Japan - Shuichi Yamaguchi
Center for Outcomes Research and Economic Evaluation for Health (C2H),
National Institute of Public Health
Saitama, Japan
Auditors
- Haku Ishida, MD, PhD
Haku Ishida, MD, PhD
Professor
Department of Medical Informatics and Decision Sciences
Yamaguchi University
Yamaguchi, Japan - Shinichiro Yanagisawa, PhD
President
Himeji Dokkyo University
Himeji, Japan
Secretary
- Makoto Kobayashi, MEng, PhD
COO
CRECON MEDICAL ASSESSMENT INC.
Tokyo, Japan